CAS: 1607837-31-9
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
CCT-251921 REF: 3D-HPC83731CAS: 1607837-31-9 | Min. 95% | To inquire | Thu 23 Jan 25 | |
CCT-251921 REF: TM-T14901CAS: 1607837-31-9 | 97.74% | 94.00 €~1,049.00 € | Thu 13 Feb 25 |
CCT-251921
CAS:1607837-31-9
CCT-251921 is a molecule that inhibits the activity of cyclin-dependent kinases (CDKs) 4 and 6. …
Formula:
C21H23ClN6O
Purity:
Min. 95%
Molecular weight:
410.9 g/mol
Ref: 3D-HPC83731
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Thursday 23 Jan 2025
CCT-251921
CAS:1607837-31-9
CCT-251921 is a potent, selective, and orally bioavailable CDK8 inhibitor (IC50: 2.3 nM).
Formula:
C21H23ClN6O
Purity:
97.74%
Color and Shape:
Solid
Molecular weight:
410.9
Ref: TM-T14901
1mg | 94.00 € | ||
5mg | 218.00 € | ||
10mg | 318.00 € | ||
25mg | 536.00 € | ||
50mg | 768.00 € | ||
100mg | 1,049.00 € | ||
1mL*10mM (DMSO) | 201.00 € |
Estimated delivery in United States, on Thursday 13 Feb 2025